Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 09 2019
Historique:
received: 13 05 2019
accepted: 11 06 2019
pubmed: 5 7 2019
medline: 8 7 2020
entrez: 5 7 2019
Statut: epublish

Résumé

Chikungunya virus (CHIKV) is a reemerged arbovirus, a member of the

Identifiants

pubmed: 31270226
pii: JVI.00775-19
doi: 10.1128/JVI.00775-19
pmc: PMC6714818
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
Vaccines, Attenuated 0
Viral Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 Carrau et al.

Références

Nat Med. 2000 Dec;6(12):1375-9
pubmed: 11100123
Am J Trop Med Hyg. 2000 Jun;62(6):681-5
pubmed: 11304054
J Mol Evol. 2002 Feb;54(2):156-65
pubmed: 11821909
Mol Biol Evol. 2002 Dec;19(12):2333-6
pubmed: 12446826
Infect Genet Evol. 2003 May;3(1):19-28
pubmed: 12797969
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
pubmed: 12824337
J Hyg (Lond). 1956 Jun;54(2):192-200
pubmed: 13346079
Trans R Soc Trop Med Hyg. 1955 Jan;49(1):33-57
pubmed: 14373835
J Virol. 2003 Oct;77(20):11296-8
pubmed: 14512579
Evolution. 2003 Sep;57(9):1959-72
pubmed: 14575319
Nat Rev Microbiol. 2004 Oct;2(10):789-801
pubmed: 15378043
Genetics. 2005 Jan;169(1):495-501
pubmed: 15466418
Virus Res. 2005 Feb;107(2):183-93
pubmed: 15649564
J Virol Methods. 2005 Mar;124(1-2):65-71
pubmed: 15664052
J Gen Virol. 2005 Aug;86(Pt 8):2175-83
pubmed: 16033965
J Virol. 2006 Apr;80(7):3259-72
pubmed: 16537593
PLoS Med. 2006 Jul;3(7):e263
pubmed: 16700631
J Virol. 2006 Oct;80(19):9687-96
pubmed: 16973573
Proc Natl Acad Sci U S A. 2008 May 13;105(19):6970-5
pubmed: 18458341
Science. 2008 Jun 27;320(5884):1784-7
pubmed: 18583614
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
J Virol. 2009 Oct;83(19):9957-69
pubmed: 19605476
Drugs Today (Barc). 2009 Jul;45(7):521-32
pubmed: 19834629
Antiviral Res. 2010 Feb;85(2):328-45
pubmed: 19857523
J Virol. 2010 Aug;84(16):8021-32
pubmed: 20519386
Nat Rev Microbiol. 2010 Jul;8(7):491-500
pubmed: 20551973
Viruses. 2010 Dec;2(12):2594-617
pubmed: 21994633
PLoS Pathog. 2011 Dec;7(12):e1002390
pubmed: 22144891
EMBO Mol Med. 2012 Apr;4(4):330-43
pubmed: 22389221
Expert Rev Vaccines. 2012 Sep;11(9):1087-101
pubmed: 23151166
Cell Host Microbe. 2012 Nov 15;12(5):623-32
pubmed: 23159052
Future Microbiol. 2013 Feb;8(2):155-76
pubmed: 23374123
Clin Exp Vaccine Res. 2012 Jul;1(1):35-49
pubmed: 23596576
PLoS Pathog. 2013;9(10):e1003678
pubmed: 24098125
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Geospat Health. 2014 May;8(2):405-15
pubmed: 24893017
Cell Host Microbe. 2014 Jun 11;15(6):706-16
pubmed: 24922573
J Virol. 2014 Dec;88(24):14364-79
pubmed: 25275138
Elife. 2014 Dec 09;3:e04531
pubmed: 25490153
Vector Borne Zoonotic Dis. 2015 Apr;15(4):231-40
pubmed: 25674945
Elife. 2015 Jun 30;4:e08347
pubmed: 26126267
PLoS Negl Trop Dis. 2015 Nov 12;9(11):e0004101
pubmed: 26562299
Trends Microbiol. 2016 Feb;24(2):134-147
pubmed: 26646373
Int J Infect Dis. 2017 May;58:69-76
pubmed: 28288924
Nat Microbiol. 2017 Jun 05;2:17088
pubmed: 28581455
Annu Rev Virol. 2017 Sep 29;4(1):181-200
pubmed: 28961411
Trends Microbiol. 2018 Jan;26(1):6-15
pubmed: 29033339
Int J Infect Dis. 2018 Feb;67:25-35
pubmed: 29196275
Clin Microbiol Rev. 2017 Dec 13;31(1):
pubmed: 29237708
Virology. 2018 Jun 20;521:138-148
pubmed: 29935423
J Immunol. 1998 Jan 15;160(2):846-53
pubmed: 9551920

Auteurs

Lucía Carrau (L)

Viral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.

Veronica V Rezelj (VV)

Viral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.

María G Noval (MG)

Department of Microbiology, New York University School of Medicine, New York, New York, USA.

Laura I Levi (LI)

Viral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.

Daniela Megrian (D)

Evolutionary Biology of the Microbial Cell Unit, Department of Microbiology, Institut Pasteur, Paris, France.

Herve Blanc (H)

Viral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.

James Weger-Lucarelli (J)

Department of Biomedical Sciences and Pathobiology, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.

Gonzalo Moratorio (G)

Viral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.
Laboratorio de Inmunovirología, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay.

Kenneth A Stapleford (KA)

Department of Microbiology, New York University School of Medicine, New York, New York, USA.

Marco Vignuzzi (M)

Viral Populations and Pathogenesis Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France marco.vignuzzi@pasteur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH